Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Influenza vaccination and major adverse vascular events in high-risk patients.

Johnstone J, Loeb M, Teo KK, Gao P, Dyal L, Liu L, Avezum A, Cardona-Munoz E, Sleight P, Fagard R, Yusuf S; Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET); Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators.

Circulation. 2012 Jul 17;126(3):278-86. doi: 10.1161/CIRCULATIONAHA.111.071100. Epub 2012 Jun 19.

2.

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.

Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, Heckbert SR, Larson EB, Weiss NS.

Int J Epidemiol. 2006 Apr;35(2):345-52. Epub 2005 Dec 20. Review.

PMID:
16368724
3.
4.

Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.

Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B.

Eur Heart J. 2004 Jan;25(1):25-31.

PMID:
14683739
5.

Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke.

Lavallée PC, Labreuche J, Fox KM, Lavados P, Mattle H, Steg PG, Amarenco P; PERFORM, OPTIC, and AMISTAD Investigators.

Neurology. 2014 May 27;82(21):1905-13. doi: 10.1212/WNL.0000000000000456. Epub 2014 Apr 30.

6.

Evidence of bias in estimates of influenza vaccine effectiveness in seniors.

Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS.

Int J Epidemiol. 2006 Apr;35(2):337-44. Epub 2005 Dec 20.

PMID:
16368725
7.

Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method.

Wong K, Campitelli MA, Stukel TA, Kwong JC.

Arch Intern Med. 2012 Mar 26;172(6):484-91. doi: 10.1001/archinternmed.2011.2038. Epub 2012 Feb 27.

PMID:
22371873
8.

Effectiveness of influenza vaccine in the community-dwelling elderly.

Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E.

N Engl J Med. 2007 Oct 4;357(14):1373-81.

9.
11.

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.

Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):943-51. doi: 10.1001/archpedi.162.10.943.

PMID:
18838647
12.

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.

Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M.

N Engl J Med. 2003 Apr 3;348(14):1322-32.

13.

Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination.

Piñol-Ripoll G, de la Puerta I, Santos S, Purroy F, Mostacero E.

Cerebrovasc Dis. 2008;26(4):339-47. doi: 10.1159/000151636. Epub 2008 Aug 27.

PMID:
18728360
14.

Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?

Eurich DT, Marrie TJ, Johnstone J, Majumdar SR.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):527-33. doi: 10.1164/rccm.200802-282OC. Epub 2008 Jun 12.

PMID:
18556629
15.

Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.

Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C.

CMAJ. 2016 Oct 4;188(14):E342-E351. Epub 2016 Jul 25.

16.

Association of influenza vaccination and reduced risk of recurrent myocardial infarction.

Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W.

Circulation. 2000 Dec 19;102(25):3039-45.

17.

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Nichol KL, Wuorenma J, von Sternberg T.

Arch Intern Med. 1998 Sep 14;158(16):1769-76.

PMID:
9738606
18.

Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort.

Kobashigawa T, Nakajima A, Taniguchi A, Inoue E, Tanaka E, Momohara S, Yamanaka H.

Scand J Rheumatol. 2013;42(6):445-50. doi: 10.3109/03009742.2013.788733. Epub 2013 Jun 3.

PMID:
23724971
19.

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.

20.

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group.

J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.

PMID:
19086915

Supplemental Content

Support Center